Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75,411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial.
Xie L, Xu J, Sun X, Guo W, Gu J, Liu K, Zheng B, Ren T, Huang Y, Tang X, Yan T, Yang R, Sun K, Shen D, Li Y. Xie L, et al. Among authors: huang y. J Immunother Cancer. 2020 May;8(1):e000798. doi: 10.1136/jitc-2020-000798. J Immunother Cancer. 2020. PMID: 32376724 Free PMC article. Clinical Trial.
miR-100-5p Inhibits Malignant Behavior of Chordoma Cells by Targeting IGF1R.
Zhang H, Yang K, Ren T, Huang Y, Liang X, Yu Y, Wang W, Niu J, Lou J, Tang X, Guo W. Zhang H, et al. Among authors: huang y. Cancer Manag Res. 2020 Jun 2;12:4129-4137. doi: 10.2147/CMAR.S252185. eCollection 2020. Cancer Manag Res. 2020. PMID: 32606920 Free PMC article.
75,411 results
You have reached the last available page of results. Please see the User Guide for more information.